HomeENLV • NASDAQ
add
Enlivex Therapeutics Ltd
Previous close
$0.92
Day range
$0.92 - $0.97
Year range
$0.81 - $1.76
Market cap
23.07M USD
Avg Volume
53.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.50M | -11.29% |
Net income | -3.45M | 16.62% |
Net profit margin | — | — |
Earnings per share | -0.15 | 31.82% |
EBITDA | -3.41M | 9.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.55M | -12.31% |
Total assets | 24.04M | -22.59% |
Total liabilities | 3.41M | -18.78% |
Total equity | 20.63M | — |
Shares outstanding | 23.76M | — |
Price to book | 1.06 | — |
Return on assets | -33.87% | — |
Return on capital | -39.15% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.45M | 16.62% |
Cash from operations | -4.62M | -2.53% |
Cash from investing | 3.17M | -37.76% |
Cash from financing | 197.00K | -62.40% |
Net change in cash | -1.25M | -212.77% |
Free cash flow | -2.15M | 25.46% |
About
Founded
Jan 22, 2012
Website
Employees
36
